RAMIPRIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ramipril, and when can generic versions of Ramipril launch?
Ramipril is a drug marketed by Accord Hlthcare, Actavis Elizabeth, Aurobindo Pharma Ltd, Chartwell Molecular, Chartwell Rx, Cipla, Corepharma, Dr Reddys Labs Ltd, Hikma, Lupin, Ranbaxy Labs Ltd, Teva Pharms, Watson Labs, Zydus Pharms Usa, Apotex, Natco Pharma, and Zydus Pharms Usa Inc. and is included in seventeen NDAs.
The generic ingredient in RAMIPRIL is ramipril. There are nineteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the ramipril profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ramipril
A generic version of RAMIPRIL was approved as ramipril by WATSON LABS on October 24th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RAMIPRIL?
- What are the global sales for RAMIPRIL?
- What is Average Wholesale Price for RAMIPRIL?
Summary for RAMIPRIL
| US Patents: | 0 |
| Applicants: | 17 |
| NDAs: | 17 |
| Finished Product Suppliers / Packagers: | 18 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 169 |
| Drug Prices: | Drug price information for RAMIPRIL |
| Drug Sales Revenues: | Drug sales revenues for RAMIPRIL |
| DailyMed Link: | RAMIPRIL at DailyMed |
Recent Clinical Trials for RAMIPRIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Menarini International Operations Luxembourg SA | Phase 4 |
| John Paul II Hospital, Krakow | Phase 3 |
| Pharmtechnology LLC | Phase 1 |
Pharmacology for RAMIPRIL
| Drug Class | Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Medical Subject Heading (MeSH) Categories for RAMIPRIL
Anatomical Therapeutic Chemical (ATC) Classes for RAMIPRIL
US Patents and Regulatory Information for RAMIPRIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranbaxy Labs Ltd | RAMIPRIL | ramipril | CAPSULE;ORAL | 078849-001 | Mar 6, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys Labs Ltd | RAMIPRIL | ramipril | CAPSULE;ORAL | 078191-004 | Jun 18, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | RAMIPRIL | ramipril | CAPSULE;ORAL | 076549-003 | Oct 24, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Natco Pharma | RAMIPRIL | ramipril | TABLET;ORAL | 090650-002 | Jun 30, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Pharms | RAMIPRIL | ramipril | CAPSULE;ORAL | 077470-003 | Jun 18, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | RAMIPRIL | ramipril | CAPSULE;ORAL | 076549-004 | Oct 24, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Apotex | RAMIPRIL | ramipril | TABLET;ORAL | 091069-001 | Dec 2, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
